| abstract |
Inhibitors of HBV replication with formula (A) Including stereochemically isomeric forms thereof, as well as salts, hydrates, solvates, wherein R a to R d , and R 5 to R 6 have the meanings as defined herein. The invention also relates to processes for the preparation of said compounds, pharmaceutical compositions containing them and their use in HBV therapy alone or in combination with other HBV inhibitors. |